The purpose of this study is to learn more about the safety of the study drugs (venetoclax and azacitidine) and how well they work compared to Best Supportive Care in patients with AML after stem cell transplant.
COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4
North Carolina (Statewide)
Katarzyna Jamieson
LCCC - Clinical Trials
Clinical or Medical
Interventional
Blood Conditions
Cancer (Leukemia)
Transplant
20-2210
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
